Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial
Ziegler, Dan, Low, Phillip A, Litchy, William J, Boulton, Andrew J.M, Vinik, Aaron I, Freeman, Roy, Samigullin, Rustem, Tritschler, Hans, Munzel, Ullrich, Maus, Joachim, Schütte, Klemens, Dyck, Peter J
Published in Diabetes care (01.09.2011)
Published in Diabetes care (01.09.2011)
Get full text
Journal Article
Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain
Forst, Thomas, Smith, Terry, Schütte, Klemens, Marcus, Paul, Pfützner, Andreas
Published in British journal of clinical pharmacology (01.07.2007)
Published in British journal of clinical pharmacology (01.07.2007)
Get full text
Journal Article
Efficacy and Safety of Antioxidant Treatment With [alpha]-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial
Ziegler, Dan, Low, Phillip A, Litchy, William J, Boulton, Andrew J M, Vinik, Aaron I, Freeman, Roy, Samigullin, Rustem, Tritschler, Hans, Munzel, Ullrich, Maus, Joachim, Schütte, Klemens, Dyck, Peter J
Published in Diabetes care (01.09.2011)
Published in Diabetes care (01.09.2011)
Get full text
Journal Article
Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy
Ziegler, Dan, Low, Phillip A., Litchy, William J., Boulton, Andrew J.M., Vinik, Aaron I., Freeman, Roy, Samigullin, Rustem, Tritschler, Hans, Munzel, Ullrich, Maus, Joachim, Schütte, Klemens, Dyck, Peter J.
Published in Diabetes care (01.09.2011)
Published in Diabetes care (01.09.2011)
Get full text
Journal Article
Dose escalating safety study of CNS 5161 HCI, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain
FORST, Thomas, SMITH, Terry, SCHÜTTE, Klemens, MARCUS, Paul, PFÜTZNER, Andreas
Published in British journal of clinical pharmacology (2007)
Get full text
Published in British journal of clinical pharmacology (2007)
Journal Article